317 related articles for article (PubMed ID: 16927029)
1. The intriguing prion disorders.
Abid K; Soto C
Cell Mol Life Sci; 2006 Oct; 63(19-20):2342-51. PubMed ID: 16927029
[TBL] [Abstract][Full Text] [Related]
2. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
3. Prions at the crossroads: the need to identify the active TSE agent.
Nandi PK
Bioessays; 2004 May; 26(5):469-73. PubMed ID: 15112226
[TBL] [Abstract][Full Text] [Related]
4. [Prions and protein inhibitors of proteinases: structural analogies and their consequences. IV. The nature of the interspecies barrier of prion disease].
Verevka SV
Ukr Biokhim Zh (1999); 2003; 75(1):115-20. PubMed ID: 14574749
[TBL] [Abstract][Full Text] [Related]
5. New insights into prion structure and toxicity.
Harris DA; True HL
Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391
[TBL] [Abstract][Full Text] [Related]
6. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone.
Saborío GP; Soto C; Kascsak RJ; Levy E; Kascsak R; Harris DA; Frangione B
Biochem Biophys Res Commun; 1999 May; 258(2):470-5. PubMed ID: 10329411
[TBL] [Abstract][Full Text] [Related]
7. Prion propagation and molecular chaperones.
Zahn R
Q Rev Biophys; 1999 Nov; 32(4):309-70. PubMed ID: 11194568
[No Abstract] [Full Text] [Related]
8. The state of the prion.
Weissmann C
Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.
Telling GC; Parchi P; DeArmond SJ; Cortelli P; Montagna P; Gabizon R; Mastrianni J; Lugaresi E; Gambetti P; Prusiner SB
Science; 1996 Dec; 274(5295):2079-82. PubMed ID: 8953038
[TBL] [Abstract][Full Text] [Related]
10. Prion hypothesis: the end of the controversy?
Soto C
Trends Biochem Sci; 2011 Mar; 36(3):151-8. PubMed ID: 21130657
[TBL] [Abstract][Full Text] [Related]
11. Do amyloids remember their origin? New insights into the prion species barrier.
Chernoff YO
Mol Cell; 2004 Apr; 14(2):147-8. PubMed ID: 15099512
[TBL] [Abstract][Full Text] [Related]
12. Prions mediated neurodegenerative disorders.
Huang WJ; Chen WW; Zhang X
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4028-34. PubMed ID: 26592824
[TBL] [Abstract][Full Text] [Related]
13. A general model of prion strains and their pathogenicity.
Collinge J; Clarke AR
Science; 2007 Nov; 318(5852):930-6. PubMed ID: 17991853
[TBL] [Abstract][Full Text] [Related]
14. Deadly conformations--protein misfolding in prion disease.
Horwich AL; Weissman JS
Cell; 1997 May; 89(4):499-510. PubMed ID: 9160742
[No Abstract] [Full Text] [Related]
15. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
16. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in stress proteins in prion diseases.
Tatzelt J; Voellmy R; Welch WJ
Cell Mol Neurobiol; 1998 Dec; 18(6):721-9. PubMed ID: 9876878
[TBL] [Abstract][Full Text] [Related]
18. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
19. Folding and misfolding of the prion protein in the secretory pathway.
Tatzelt J; Winklhofer KF
Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology and pathogenesis of prion diseases.
Prusiner SB
Trends Biochem Sci; 1996 Dec; 21(12):482-7. PubMed ID: 9009832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
